As the race to develop targeted therapies continues, pharmaceutical companies seek to create a competitive advantage by developing new treatments for actionable biomarkers.
The clinical trial's success is strongly dependent on a company's ability to recruit eligible patients with a higher predictive responsiveness factor.
It is estimated that up to 80% of clinical trials fail to meet enrollment timelines, while 26% of rare diseases trials are terminated because of low accrual rates
lmagene is pharma's first choice for an optimized drug development, clinical trials design and enrollment,
and companion diagnostics solutions
Optimized clinical trial enrollment, design, and success
AI-enabled Companion Diagnostics for Precision Oncology
Drug Development Optimization
Cookie | Duration | Description |
---|---|---|
CookieLawInfoConsent | 1 year | Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie. |
Cookie | Duration | Description |
---|---|---|
wordpress_google_apps_login | session | This is a functional cookie used for WordPress. |
Cookie | Duration | Description |
---|---|---|
_ga | 2 years | The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors. |
_gid | 1 day | Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously. |